Skip navigation

Chemical angiotensin-II, Sar-Arg-Val-Tyr-Val-His-Pro-(2',3',4',5',6'-pentabromo)-Phe

Name angiotensin-II, Sar-Arg-Val-Tyr-Val-His-Pro-(2',3',4',5',6'-pentabromo)-Phe
Equivalent Terms angiotensin-II, Sar-Arg-Val-Tyr-Val-His-Pro-(2',3',4',5',6'-pentabromo)-Phe, (L,L,L,L,L,L,D)-isomer | angiotensin II, sarcosyl-arginyl-valyl-tyrosyl-valyl-histidyl-prolyl(2',3',4',5',6'-pentabromo)-phenylalanine | Br5-angiotensin II | Sar-Arg-Val-Tyr-Val-His-Pro-(2',3',4',5,'6'-pentabromo)-Phe-angiotensin II
CAS Registry Number 87023-81-2
Curation Status No associations have been curated for this chemical yet.
MeSH® ID C059928
External Links

Top ↑ Ancestors

1. ChemicalsHormones, Hormone Substitutes, and Hormone Antagonists Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Hormones Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Peptide Hormones Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Angiotensins Has associated genes Has associated diseases Has associated phenotype references Angiotensin II Has associated genes Has associated diseases Has associated phenotype references angiotensin-II, Sar-Arg-Val-Tyr-Val-His-Pro-(2',3',4',5',6'-pentabromo)-Phe
2. ChemicalsAmino Acids, Peptides, and Proteins Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Peptides Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Neuropeptides Has associated genes Has associated diseases Has associated phenotype references Angiotensins Has associated genes Has associated diseases Has associated phenotype references Angiotensin II Has associated genes Has associated diseases Has associated phenotype references angiotensin-II, Sar-Arg-Val-Tyr-Val-His-Pro-(2',3',4',5',6'-pentabromo)-Phe
3. ChemicalsAmino Acids, Peptides, and Proteins Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Peptides Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Oligopeptides Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Angiotensins Has associated genes Has associated diseases Has associated phenotype references Angiotensin II Has associated genes Has associated diseases Has associated phenotype references angiotensin-II, Sar-Arg-Val-Tyr-Val-His-Pro-(2',3',4',5',6'-pentabromo)-Phe
4. ChemicalsAmino Acids, Peptides, and Proteins Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Peptides Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Peptide Hormones Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Angiotensins Has associated genes Has associated diseases Has associated phenotype references Angiotensin II Has associated genes Has associated diseases Has associated phenotype references angiotensin-II, Sar-Arg-Val-Tyr-Val-His-Pro-(2',3',4',5',6'-pentabromo)-Phe
5. ChemicalsBiological Factors Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Inflammation Mediators Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Autacoids Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Angiotensins Has associated genes Has associated diseases Has associated phenotype references Angiotensin II Has associated genes Has associated diseases Has associated phenotype references angiotensin-II, Sar-Arg-Val-Tyr-Val-His-Pro-(2',3',4',5',6'-pentabromo)-Phe

Top ↑ Descendants

None.